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Jensen EB, Zheng D, Russell RA, Bassel-Duby R, Williams
RS, Olson AL, Dohm GL. Regulation of GLUT4 expression in
denervated skeletal muscle. Am J Physiol Regul Integr Comp
Physiol 296: R1820 –R1828, 2009. First published March 25,
2009; doi:10.1152/ajpregu.90651.2008.—Denervation by sciatic
nerve resection causes decreased muscle glucose transporter 4
(GLUT4) expression, but little is known about the signaling events
that cause this decrease. Experiments were designed to test the
hypothesis that decreased GLUT4 expression in denervated muscle
occurs because of decreased calcium/CaMK activity, which would
then lead to decreased activation of the transcription factors myocyte
enhancer factor 2 (MEF2) and GLUT4 enhancer factor (GEF), which
are required for normal GLUT4 expression. GLUT4 mRNA was
elevated in mice expressing constitutively active CaMK isoform IV
(CaMKIV) and decreased by denervation. Denervation decreased
GEF binding to the promoter and the content of GEF in the nucleus,
but there was no change in either MEF2 binding or MEF2 protein
content. Expression of a MEF2-dependent reporter gene did not
change in denervated skeletal muscle. To determine the domains of
the GLUT4 promoter that respond to denervation, transgenic mice
expressing the chloramphenicol acetyl transferase (CAT) reporter
gene driven by different lengths of the human GLUT4 promoter were
denervated. Using several different promoter/reporter gene constructs,
we found that all areas of the GLUT4 promoter were truncated or
missing, except for the MEF2 binding domain and the basal promoter.
All of the GLUT4 promoter/CAT reporter constructs evaluated re-
sponded normally to denervation. Our data lead us to conclude that
decreased CaMK activity is not the reason for decreased GLUT4
content in denervated muscle and that negative control of GLUT4
expression is not mediated through the MEF2 or GEF-binding do-
mains. These findings indicate that withdrawal of a GEF- or MEF2-
dependent signal is not likely a major determinant of the denervation
effect on GLUT4 expression. Thus, the response to denervation may
be mediated by other elements present in the basal promoter of the
GLUT4 gene.
denervation; exercise; myocyte enhancer factor 2; GLUT4 enhancer
factor; glucose
THE TOTAL AMOUNT OF GLUT4 protein in a cell is important for
maximal glucose transport rates. Whole body glucose disposal
and GLUT4 protein levels are correlated in humans (5, 20),
with exercise training (10–12) and aging (13). Studies in
transgenic mice show that the correlation between GLUT4 and
glucose homeostasis is one of cause and effect (19). Mice
overexpressing GLUT4 specifically in skeletal muscle have
improved whole body insulin action, more rapid glucose clear-
ance from the blood, a higher rate of muscle glucose transport,
and improved glucose homeostasis (15, 21, 35, 42, 43). Over-
expression of GLUT4 in genetically diabetic ob/ob mice im-
proved glycemic control and ameliorated diabetes (3, 7, 16).
While decreased GLUT4 content is not responsible for insulin
resistance, increased GLUT4 is capable of rescuing or prevent-
ing insulin resistance, and ways to increase GLUT4 content
could be used to treat type II diabetes (49). For this reason, it
is very important that we learn how GLUT4 expression is
regulated, so we can develop therapies for treating diabetes.
Studies of how active muscle states, such as exercise, increase
GLUT4 content have produced valuable information on how
GLUT4 expression is regulated. Another way to gain informa-
tion about GLUT4 gene expression is by studying the negative
regulation of GLUT4 expression in inactive muscle states such
as denervation.
Denervation by sciatic nerve resection decreases muscle
GLUT4 mRNA and protein 50% 3 to7 days after denervation
(2, 4). Denervation of the rat hindlimb muscles leads to a
reduction in both GLUT4 content and uptake of the nonme-
tabolizable glucose analog, 3-OMG (29), and loss of GLUT4
content is highly correlated with a reduction in insulin-stimu-
lated glucose uptake (4). GLUT4 protein expression in dener-
vated tissue appears to be dependent on changes in mRNA,
which are regulated by decreased transcription rates of the
GLUT4 gene (18).
Expression of GLUT4 is highly dependent on the transcrip-
tion factors GLUT4 enhancer factor (GEF) and myocyte en-
hancer factor 2 (MEF2). GEF is the binding protein for the
GLUT4 promoter element, Domain I. Domain 1 is the region
between 742 bp and 712 bp upstream of the GLUT4
transcription initiation site (33). The MEF2-binding site is
located between 473 bp and 464 bp of the GLUT4 gene
promoter (41). Domain 1 and the MEF2-binding site cooperate
to support the pattern of expression that endogenous GLUT4
follows (33). Regulated and tissue-specific expression of the
GLUT4 gene occurs only in tissues in which sufficient GEF
and MEF2 binding activity coincide. In differentiated muscle,
MEF2 is required for GLUT4 mRNA expression (38, 41), and
in mice expressing a reporter gene controlled by the GLUT4
gene promoter, mutation of the MEF2 binding domain was
shown to result in a complete lack of reporter gene expression
(6, 41). Confirming the imperative nature of MEF2 as a
regulator of GLUT4 transcription, mutation of the MEF2
binding site in C2C12 cells also resulted in loss of function of
the GLUT4 gene and decreased GLUT4 mRNA (22).
CaMK has been shown to be capable of activating MEF2.
MEF2 proteins function in skeletal muscle as downstream
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effectors of calcium-regulated signaling pathways stimulated
by motor nerve activity and its subsequent muscle contraction.
In this way, MEF2 contributes to fiber-type-specific gene
regulation (47, 48). CaMK allows MEF2 to become activated
because CaMK phosphorylates inhibitory histone deacetylase
(HDAC) proteins resulting in their dissociation from MEF2
and their export from the nucleus (8, 27, 44). Little is known
about GEF regulation and whether GEF responds to calcium-
signaling pathways.
Experiments were designed to test the hypothesis that de-
creased GLUT4 expression in denervated muscle occurs be-
cause of decreased CaMK activity in the noncontracting mus-
cle. Decreased CaMK activity would then lead to depressed
transcriptional activation by MEF2 and GEF. To test the role of
calcium signaling in regulation of GLUT4 expression in de-
nervated muscle, GLUT4 mRNA was measured in muscle of
wild-type mice and mice expressing constitutively active
CaMKIV.
To determine how GEF and MEF2 DNA binding activity
change during denervation, we performed electrophoretic mo-
bility shift assays using oligonucleotides corresponding to their
cognate binding sites. Mice that express a lacZ reporter gene,
expression of which is dependent on a gene promoter rich in
MEF2 sequences, were also denervated to determine the ability
of MEF2 to stimulate or repress gene expression in denervated
muscle. To discover the responsible elements in the GLUT4
promoter, we denervated transgenic mice expressing the chlor-
amphenicol acetyl transferase (CAT) reporter gene driven by
different regions of the human GLUT4 promoter. We hypoth-
esized that there would be no change in CAT expression after
denervation in a transgenic mouse that did not have sufficient
portion of the GLUT4 promoter to respond to denervation. In
this study, new transgenic lines with promoter regions consist-
ing of 895 bp of GLUT4 promoter minus deleted regions
between 712 to 526 bp or 440 to 220 bp were dener-
vated along with a line with 730 bp of promoter driving the
expression of CAT. Each transgenic mouse line tested has
different deleted portions of the GLUT4 promoter, but collec-
tively, the mice have nearly the entire GLUT4 promoter
deleted, or rendered ineffective, except for the MEF2 binding
domain and the basal promoter (about 200 bp upstream of the
initiation site).
MATERIALS AND METHODS
Mice. All procedures were approved by the Institutional Animal
Care and Use Committee of East Carolina University. Mice were
housed with room temperature and lighting controlled (20–22°C:
12:12-h light-dark cycle) and were given food and water ad libitum.
Transgenic mice were identified by PCR using primers specific for
their respective transgenes. The mice expressing constitutively active
CaMKIV (CaMKIV-TG) (34) have been described previously. The
MEF2/reporter mice were previously studied (31) and were graciously
provided by Dr. Eric Olson (University of Texas Southwestern Med-
ical Center). Mice expressing the CAT reporter gene controlled by
different regions of the hGLUT4 gene promoter (hGLUT4-CAT)
were produced at the Oklahoma Health Sciences Center and have
been previously described (23, 32, 41). At the specified times after
treatment, the mice were killed by CO2 asphyxiation. The background
strain of all mice used in these studies was C57BL/6. Because the
CaMK transgene expression is driven by the muscle creatine kinase
(MCK) promoter, and because MCK is expressed at a higher level in
white muscle fibers, plantaris muscle was used for RNA measure-
ments in CaMK-transgenic mice. Gastrocnemius muscle was used in
all other studies.
Materials. Primary antibodies were purchased from Santa Cruz
(MEF2 H-300) and Abcam (GLUT4). GEF primary antibody was
isolated and purified as previously described (33). Unless otherwise
specified, all other reagents were purchased from Sigma Chemical (St.
Louis, MO), Pierce Chemical (Rockford, IL), or Fisher Scientific
(Springfield, NJ).
Denervation study. The mice were anesthetized with an intraperi-
toneal injection of a ketamine (18 mg/ml)-xylazine (2 mg/ml) mixture
(0.05 ml/10 g body wt), and their hindquarters were shaved in
preparation for surgery. As described by Megeney et al. (29), a small
incision was made in the posterior aspect of the hindlimb to expose
the sciatic nerve at the level of the femoral trochanter. After severing
the sciatic nerve, the same surgical procedure was performed to the
contralateral hindlimb without resectioning of the sciatic nerve. The
incision was closed with Autoclips, and the animals recovered for 3
days before tissue was harvested. The recovery of the animals was
closely monitored, and there were no overt signs of animal distress or
pain after denervation. Seventy-two hours after denervation, mice
were killed by CO2 asphyxiation, and the harvested muscles were
quick-frozen to liquid nitrogen temperature.
RNA isolation. A 10- to 100-mg sample of muscle was homoge-
nized in 1 ml of TRIzol reagent (Invitrogen) with 5  107 g/ml
glycogen. Homogenates were treated with DNase from Qiagen (Va-
lencia, CA). Qiagen RNeasy minicolumn isolation kits were used to
isolate RNA, and RNA was quantified using the RiboGreen RNA
quantitation kit (Molecular Probes, Eugene, OR).
RNase protection assays. Radiolabeled ([32P]UTP, 800 Ci/
mmol) antisense RNA probes were transcribed from the pTRI-
GAPDH (glyceraldehyde 3-phosphate dehydrogenase)-mouse anti-
sense control template (Ambion, Austin, TX) and the Bsu 361 linear-
ized mouse GLUT4-CAT plasmid, p469GLUT4-CAT (32), using
Ambion’s T3/T7 MAXIscript in vitro transcription kit. Briefly, RNase
protection assays (RPAs) were performed with the streamlined pro-
cedure of Ambion’s RPA II kit, as previously described (17, 18). Ten
micrograms total RNA per sample and 32P-labeled antisense probes
were hybridized overnight at 45°C. Nonhybridized RNA was digested
for 1 h at 37°C with 1:1,000 dilution of RNase T1/A from RPA II kit.
The protected RNA fragments were separated by using 6% acryl-
amide 7.5 M urea gel electrophoresis and were then exposed to
PhosphorImager and quantitated with Imagequant software (Molecu-
lar Dynamics, Sunnyvale, CA). The size of the protected fragments
was estimated by RNA transcripts labeled with [32P]UTP from
Century Marker Templates (Ambion) by using T7 RNA polymerase.
Endogenous GLUT4 and CAT measurements were normalized to
GAPDH measurements. GAPDH was chosen as an appropriate normal-
izer for the data because of its lack of responsiveness to denervation.
Electrophoretic mobility shift assay. Electrophoretic mobility shift
assays were done as described previously (33). Oligonucleotides were
end-labeled with T4 polynucleotide kinase. Labeled probes (0.5 ng)
were incubated with 10 mg of total protein isolated from nuclei in a
10-ml reaction containing 2 mg of poly(dI-dC), 40 mM KCl, 5 mM
MgCl2, 15 mM HEPES, pH 7.9, 1 mM EDTA, 0.5 mM DTT, and 5%
glycerol for 20 min at room temperature. For competition studies,
extracts were preincubated with various concentrations of unlabeled
oligonucleotide, as indicated for 5 min before the addition of the
radiolabeled probe. For competition studies using antibodies, extracts
were preincubated with 2.5 mg of preimmune IgG, anti-GST-MEF2
IgG, or IgG from an irrelevant antiserum raised against a glutathione
S-transferase (GST) fusion protein. Preincubation was carried out for
1 h on ice before the addition of the radiolabeled probe. Samples were
electrophoresed on a nondenaturing 6% polyacrylamide gel (29:1
acrylamide:bis acrylamide) buffered with Tris borate/EDTA (TBE; 22
mM Tris, 22 mM boric acid, and 0.5 mM EDTA) at 300 V for 25 min
at room temperature. Gels were dried and an exposure of them were
made on film at room temperature.
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Quantitative RT-PCR. Quantitative RT-PCR (QRT-PCR) was used
to analyze GLUT4 mRNA content in whole muscle samples from
CaMKIV-transgenic mice, MEF2/reporter mice, and wild-type con-
trols, according to the protocol described previously (30). After
quantification of RNA, cDNA was synthesized with the reverse
transcriptase reaction, using the iScript RT kit (Bio-Rad, Hercules,
CA). Quantitative real-time PCR was performed using an ABI Prism
7300 Sequence Detection System instrument and software (PE Ap-
plied Biosystems, Foster City, CA). Prevalidated GLUT4 and lacZ
primer/probe sets were purchased from PE Applied Biosystems.
GLUT4 and lacZ mRNA values were normalized to 18s rRNA to
correct for slight differences in sample substrate.
Nuclear isolation. Nuclear protein was isolated from gastrocnemius
muscle using the NE-PER nuclear extraction kit (NE-PER; Pierce,
Rockford, IL), as previously explained (25). Briefly, muscle samples
were homogenized with 15 passes of a glass-on-glass tissue homog-
enizer in 10 volumes of cytoplasmic extraction reagent I. Cytoplasmic
extraction reagent II was added at a final concentration of 5%, and the
homogenate was spun in a centrifuge at 16,000 g for 5 min. The
supernatant was extracted, and the pellet was resuspended in 100 l
of nuclear extraction reagent and sat on ice for 40 min with occasional
mixing. The resuspended pellet was again spun in a centrifuge at
16,000 g for 10 min, and the supernatant, representing nuclear protein,
was extracted and stored.
Protein sample preparation. Powdered muscle was homogenized
(2  20 s) on ice in homogenization buffer containing 50 mM
N-2-hydroxyethylpiperazine-N-ethane (HEPES) (pH 7.4), 10 mM
EDTA, 100 mM NaF, 50 mM Na pyrophosphate, 10 mM Na or-
thovanadate, 0.1 mg/ml aprotinin, 1% Triton, 5 l/ml protease inhib-
itor cocktail, and 10 l/ml phosphatase inhibitor cocktails I and II
(Pierce) with an Ultra-Turrax homogenizer (IKA, Wilmington, NC).
For measurement of total protein, samples were centrifuged, after
homogenization, at 15,000 g for 10 min at 4°C. The supernatant was
removed and stored on ice for protein quantitation.
For isolation of membrane-associated proteins, samples were cen-
trifuged at 150,000 g for 1 h at 4°C. The pellet was resuspended by
homogenization (2  10 s) on ice in homogenization buffer with an
Ultra-Turrax homogenizer (IKA, Wilmington, NC). 1% IGEPAL
detergent was added, and samples were mixed by shaking at 4°C for
1 h. After a second centrifugation, the supernatant (particulate frac-
tion) was collected and stored on ice for measurement of protein
content followed by Western blot analysis. All samples were mea-
sured for protein content in triplicate by bicinchoninic acid procedure.
Western blot analyses. Proteins were resolved by SDS-PAGE on
7.5% or 10% Criterion resolving gels (Bio-Rad) at 200 V for 1 h in
running buffer containing 25 mM Tris, 19.2 mM glycine and 0.1%
SDS. Samples were then transferred at 100 V for 2 h to Immobilon-P
polyvinylidene difluoride membrane in transfer buffer containing 25
mM Tris, 19.2 mM glycine. Membranes were then blocked with 5%
nonfat milk with 1% BSA in 10 mM Tris-buffered saline (TBS)
solution overnight at 4°C. The membranes were incubated for 1 h with
primary antibody at room temperature in 5% nonfat milk/TBS or 5%
BSA/TBS, according to antibody manufacturer protocol. Membranes
were washed (4  5 min in TBST) and incubated with anti-rabbit-
HRP or anti-goat-HRP conjugated antibodies in 5% milk/TBST at
room temperature for 1 h. Membranes were incubated in Super Signal
West Pico luminescence solution (Pierce), according to manufacturer
protocol and exposed to film. Films were scanned using Epson
Perfection 3200 negative flatbed scanner (Epson America, Long
Beach, CA), and band density was quantified using GelPro Analyzer
Software (Media Cybernetics, Silver Spring, MD).
Statistical analysis. For comparison of mRNA and protein content
in control and denervated wild-type and transgenic mice, two-way
ANOVA was used to identify statistical differences. An independent
samples t-test was used for post hoc comparison of groups only after
main effects were shown by two-way ANOVA. Results are reported
as means  SE. Comparison of control and denervated groups were
performed by paired t-tests. All statistical analyses were performed
with Statistical Package for the Social Sciences (SPSS; v. 11.0,
Chicago, IL).
RESULTS
All mice included in this study were hindlimb denervated by
sciatic nerve resection, which leaves the lower part of the
hindlimb unable to contract. The contralateral sham-operated
muscle served as the control. There was a main effect of
denervation and expression of CaMKIV. Denervation in wild-
type control mice resulted in a 68% decrease in GLUT4 mRNA
in the plantaris muscle, and CaMKIV expression increased the
amount of GLUT4 mRNA by 30% in the control muscle of
transgenic mice (CaMK IV-TG Cont) compared with control
muscle of wild-type mice (WT Cont) (Fig. 1). While expres-
sion of CaMK IV did not protect against the typical denerva-
tion response, as GLUT4 mRNA decreased by 54% (P  5 
105) in denervated muscle, expression of CaMK IV in dener-
vated muscle was sufficient to cause GLUT4 mRNA to be 87%
higher in transgenic vs. wild-type mice (P  0.02).
The mechanism responsible for depressed GLUT4 expres-
sion is decreased gene transcription. Because binding of GEF
and MEF2 to their respective binding domains on the GLUT4
promoter is necessary for normal GLUT4 transcriptional reg-
ulation (33), we tested the activity of GEF and MEF2 in
denervated skeletal muscle by performing EMSAs to deter-
mine binding of GEF and MEF2 to their respective binding
domains in the GLUT4 promoter region in gastrocnemius
muscle. EMSAs for MEF2 and GEF were followed up by
measuring nuclear and whole tissue (total) GEF and MEF2
protein in gastrocnemius muscle by Western blot analysis.
EMSAs were performed to determine whether GEF binding
changed after denervation. GEF binding decreased after dener-
vation by 50% (P  0.05) compared with GEF binding to
Domain 1 in control muscles (Fig. 2). The nuclear and whole
Fig. 1. The effect of denervation on GLUT4 content in plantaris muscle of
wild-type mice and mice expressing constitutively active CaMKIV (CaMKIV-
TG). All GLUT4 mRNA values were normalized to the average GLUT4
mRNA value for the nondenervated wild-type control group. There was a main
effect of denervation (P  6  1011) and a main effect of transgene (P 
0.0002) but no significant interaction. *P  2  1014 for the comparison
between nondenervated wild types and denervated wild types. #P  0.02 for
the comparison between nondenervated wild-type and nondenervated trans-
genic mice. 	P  5  105 for the comparison between control and
denervated CaMK IV transgenic mice. n  22 for both wild-type mice groups.
n  18 for the nondenervated CaMKIV transgenic group. n  15 for
denervated transgenic mice.
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cell content levels of GEF after denervation in wild-type mice
were then determined. Surprisingly, we found that denervation
had no effect on nuclear GEF content (Fig. 3A), but GEF
content in the whole tissue lysates (Fig. 3B) showed a strong
trend for a 42% decrease (P  0.077).
To investigate the role of MEF2 in the regulation of GLUT4
in response to denervation, MEF2A/D levels were measured in
the nuclear and whole tissue protein extracts in the gastrocne-
mius after denervation. Nuclear content of MEF2A/D showed
a strong trend toward being higher (129% increase; P 0.079)
in denervated muscle compared with control muscle (Fig. 4A)
and total MEF2A/D protein was 125% more abundant (P 
0.03) in denervated muscle compared with control (Fig. 4B).
To determine the ability of MEF2 to stimulate transcription,
transgenic mice developed to demonstrate activation of MEF2
activity were also denervated. These mice express a lacZ
reporter gene controlled by a synthetic promoter containing
three repeats of the MEF2 binding site (Fig. 5A). Measurement
of 
-galactosidase mRNA, the lacZ gene product, in gastroc-
nemius muscle by QRT-PCR after 72 h of denervation showed
that there was no change in expression of the reporter gene
after denervation (Fig. 5B). EMSA analysis was performed to
test for MEF2 binding to the GLUT4 promoter in denervated
gastrocnemius. EMSA analysis showed no change in MEF2
binding to the GLUT4 promoter in denervated vs. nondener-
vated muscle (Fig. 5C). These data both suggest that the ability
of MEF2 to stimulate transcription is not impaired by dener-
vation.
Another approach to investigate transcriptional regulation is
to determine the DNA sequences of the promoter that are
required for the denervation response. Using mice with re-
porter gene constructs expressing the CAT reporter gene con-
Fig. 3. The effect of denervation on nuclear (A) and GEF whole cell (B)
content in gastrocnemius muscle. GEF levels were normalized to the average
value for nondenervated muscle. For A, n  5 per group; for B, n  9 per
group.
Fig. 4. The effect of denervation on nuclear (A) and whole cell (B) MEF2A/D
content in denervated gastrocnemius muscle. Nuclear MEF2 values were
normalized to the average value of nuclear MEF2 protein in nondenervated
muscle. For A, n  8 per group. For B, *P  0.03 for the comparison between
the control and denervated group; n  9 per group.
Fig. 2. The effect of denervation on GLUT4 enhancer factor (GEF) binding to
domain I in gastrocnemius muscle. A: cmparison of GEF binding to the
GLUT4 promoter in control and denervated gastrocnemius. B: representative
EMSA gel from this experiment. N, nonimmune antibody; G, GEF antibody.
*P  0.05 for the comparison between control and denervated samples. n 
6 per group.
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trolled by segments of the hGLUT4 promoter of different
lengths, our laboratory has shown that there are no denerva-
tion-responsive elements above895 bp from the transcription
initiation site. To further understand what elements may be
responsible for the large decrease in GLUT4 expression after
denervation, hGLUT4-CAT reporter mice were used again to
identify areas of the promoter that negatively influence GLUT4
in response to denervation. Mice were denervated and, after
72 h, gastrocnemius muscles were removed, and mRNA was
isolated and prepared for measurement of CAT mRNA by
QRT-PCR or RPA.
Mice with 895 bp of the hGLUT4 promoter controlling
expression of the CAT reporter gene were denervated and
mRNA was isolated from the gastrocnemius. CAT mRNA was
measured by RPA and was found to be decreased by 57% (P
0.03) in denervated muscle compared with controls (Fig. 6A).
Fig. 6. The effect of denervation on CAT mRNA expression in gastrocnemius muscle of mice expressing the CAT reporter gene controlled by the following
lengths of hGLUT4 promoter: 895 bp (A), 730 bp (B), 895 bp with a deletion between the GEF and MEF2 binding sites (D), and 895 bp with a deletion between
the MEF2 binding site and the basal promoter (F). CAT mRNA content values were normalized to the average for the control group. A: *P  0.03 for the
comparison between nondenervated control muscles and denervated muscles. n  4 mice per group. B: *P  0.01 for the comparison of the control and
denervated muscle groups. n  4 mice per group. C: schematic representing the general architecture of the hGLUT4 promoter driving CAT expression. D: *P 
4  105 for the comparison between control and denervated muscles. n  5 mice per group. E: schematic of the promoter controlling CAT expression in these
mice. F: *P  0.0001 for the comparison of mRNA level between the control and denervated groups; n  5 mice per group.
Fig. 5. The effect of denervation on MEF2
activity in denervated gastrocnemius mus-
cle. A: schematic of the synthetic MEF2-rich
promoter controlling expression of the lacZ
reporter gene. B: expression of the MEF2-
dependent reporter gene, mRNA (n  7 per
group). C: representative EMSA for MEF2
binding to the GLUT4 promoter in dener-
vated and control tissue.
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When mice with 730 bp of hGLUT4 promoter were denervated
and mRNA from the plantaris was measured by QRT-PCR,
CAT reporter expression was found to be decreased by 93%
(P  0.01) (Fig. 6B). This result demonstrates that the dener-
vation responsive element is within the first 730 base pairs of
the GLUT4 promoter. Because the GEF binding domain,
Domain I, is disrupted in the 730 bp mice, the normal dener-
vation response in muscle with this reporter construct indicates
that the decrease in GLUT4 expression does not require that
Domain I be intact.
Because deletion of the MEF2 or the GEF site results in loss
of GLUT4 expression, we turned to two lines of mice that had
895 bp of the hGLUT4 promoter but with large deleted
sections between known vital elements. The first of these new
GLUT4-reporter mice has a deletion between bases 711 and
526 (Fig. 6C). These mice were denervated, and CAT re-
porter mRNA from the gastrocnemius was measured by RPA
(Fig. 6D). Denervation decreased the amount of CAT mRNA
in the gastrocnemius by 85% (P  4  105). This demon-
strates that the denervation responsive element does not likely
exist between the MEF2 and GEF binding domains.
Another similar group of mice with the typical 895 bp
GLUT4 promoter but with a deleted region between bases
220 and 440 was denervated (Fig. 6E). CAT reporter
mRNA was measured from the gastrocnemius muscle of these
mice by QRT-PCR, and they were found to have an 80%
decrease in CAT mRNA (P  0.0001) (Fig. 6F). This result
shows that the denervation response element is not likely
within the promoter region between the MEF2 binding domain
and the basal promoter.
DISCUSSION
The experiments of this study were designed to test the
hypothesis that decreased GLUT4 expression in denervated
skeletal muscle is due to depressed activity of CaMK, which
then leads to decreased activation of the transcription factors
MEF2 and GEF. To test the role of CaMK signaling in regulation of
GLUT4 expression in denervated muscle, GLUT4 mRNA was
measured in wild-type mice and mice expressing constitutively
active CaMKIV. Normal CaMK signaling may not be accu-
rately restored by expressing a constitutively active CaMK to
make up for the loss of signaling through the diminished
sporadically activated CaMK. However, we felt a loss of
GLUT4 expression in denervated mice, with presumptively
lower CaMK signaling, and an increase in GLUT4 in a mouse
with constitutively active CaMK still made investigating the
expression of GLUT4 in a denervated CaMK-transgenic mouse
interesting for the purpose of determining whether increased
CaMK signaling could attenuate the loss of GLUT4 expression
in denervated muscle.
CaMKIV is not expressed in skeletal muscle and the major
CaMK isoform in human and rodent muscle is CaMKII (1, 36,
37). CaMKII becomes active when bound by calcium/calmod-
ulin and maintains its activity through autophosphorylation.
Phosphorylation of CaMKII causes it to move to the nucleus.
CaMKIV is typically located in the nucleus and becomes
activated by calcium/calmodulin and by phosphorylation by
CaMKK (39). We believe that CaMKIV may be a suitable
surrogate for CaMKII because 1) CaMKII and CaMKIV share
many common substrates, such as MEF2A and class II HDAC
proteins, which seem likely to regulate MEF2 action, and thus
GLUT4 expression (24, 27), 2) CaMKIV has been shown to
be functional in skeletal muscle after it is expressed (46),
3) CaMKII is a large heteromeric protein, which because of its
complexity, is much more difficult to study than the mono-
meric CaMKIV overexpression models (14). For this reason,
we feel that mice that express constitutively active CaMKIV
are good candidates for study of CaMK signaling in muscle
(14), particularly in the study of GLUT4.
We expect that, had we been able to study mice with
activated CaMKII, the results would have been similar to those
observed in the CaMKIV model. CaMKII and CaMKIV share
many common substrates, such as MEF2A and class II HDAC
proteins, which seem likely to regulate MEF2 action, and thus
GLUT4 expression (24, 27). In humans, one acute bout of
exercise increased promoter binding of MEF2. MEF2A in-
creased in the nucleus, but MEF2D did not (25). After one bout
of acute swimming in rats, MEF2A binding to the GLUT4
promoter was increased. In CaMKIV-transgenic mice, ChIP
assays were done to show that MEF2A binding to the GLUT4
promoter was increased. This study showed also that CaMKIV
and CaMKII have MEF2A as a common substrate (40).
In other experiments, when we exercise trained these mice
on a running wheel for 2 wk, there was a significant increase in
GLUT4 in wild-type mice. CaMK-transgenic mice, however,
had no increase in the amount of GLUT4 mRNA or protein in
response to exercise. This suggests that CaMK stimulation in
trained muscle plays a prominent role, since regulation by a
pathway different than CaMK would be expected to generate
an additive increase in GLUT4 content in exercised CaMK-
transgenic mice. The results of this study provide evidence that
CaMKIV activates the same signals as CaMKII and that these
CaMK-dependent signals are of major importance in regulating
GLUT4 expression. If CaMKIV and CaMKII had separate
signaling pathways, then transgenic expression of CaMKIV
and exercise would have had additive effects.
Control muscle of CaMK-transgenic mice had significantly
more GLUT4 mRNA than control muscle of wild-type mice,
but CaMKIV expression was not able to maintain GLUT4
expression levels in denervated muscle. Although there was a
significant decline in GLUT4 mRNA content after denervation,
there was significantly more GLUT4 in muscle of denervated
CaMK-transgenic mice compared with wild-type mice. This is
similar to previous work in our lab with AMPK (9). AMPK
activation by AICAR administration was sufficient to increase
the expression of GLUT4 in muscle, but AMPK was not able
to maintain GLUT4 content when challenged with denervation.
The increase in muscle GLUT4 content in exercised muscle
is thought to result from increased activity of CaMK (unpub-
lished data) and AMPK (reviewed in Ref. 45), although AMPK
has been shown not to be required for the GLUT4 exercise
response to occur (9). Supporting our hypothesis that CaMK
causes increased production of GLUT4 after exercise is the
finding that HDAC5, a CAMK-responsive transcriptional core-
pressor, inhibits GLUT4 expression (26), and the finding that,
similar to exercise, CaMK increases the binding of MEF2A to
the GLUT4 promoter. Although CaMK may mediate the ex-
ercise response of GLUT4, this study, in which mice express-
ing constitutively active CaMK had typical decreases in
GLUT4 after denervation, has proven that the main cause for
decreased GLUT4 content in denervated muscle is not de-
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creased activity of CaMK. Megeney et al. (28) compared the
difference in GLUT4 response to denervation and muscle
inactivity. Glucose transport was decreased to the same extent
in denervated muscles and muscles rendered noncontractile,
but with the motor nerve still intact, by TTX superfusion of the
sciatic nerve. However, GLUT4 content was decreased to a
much greater extent in denervated muscles compared with
TTX-treated muscles (28). These data indicated that denerva-
tion is a mixed model of muscle inactivity and elimination of
neural signaling and delivery of neural trophic factors to the
nerve, with the elimination of neural effects having a more
profound role on GLUT4 content than muscle inactivity.
Having found that loss of CaMK signaling does not mediate
the decrease in GLUT4 in denervated muscles, we investigated
the content and activity of the putative GLUT4 transcription
factors GEF and MEF2 to determine whether signaling regu-
lating GLUT4 was mediated by GEF and MEF2. Binding of
both GEF and MEF2 to their respective binding domains on the
GLUT4 promoter is necessary for normal GLUT4 transcrip-
tional regulation. EMSAs were performed to determine bind-
ing of GEF and MEF2 to their respective binding domains in
the GLUT4 gene promoter. In addition, nuclear and whole
tissue (total) GEF and MEF2 protein were determined by
Western blot analysis. EMSAs suggested there was no change
in MEF2 binding to the GLUT4 promoter. MEF2A/D protein
tended to increase with denervation as denervated muscle had
significantly higher total MEF2A/D and a trend (P  0.08) for
increased nuclear MEF2A/D protein. The lack of change in
MEF2 binding and no change in MEF2 protein in the nucleus
are consistent with a lack of change in nuclear HDAC5
(unpublished data) content in nuclei from denervated gastroc-
nemius.
The lack of regulation of MEF2 in denervation is also
demonstrated by the results of an experiment with mice ex-
pressing an MEF2-dependent lacZ reporter gene. Reporter
gene expression did not decrease after denervation, as it would
have if MEF2 had taken on an inhibitory role in the denervated
state. These MEF2 reporter mice have been used in the past to
show that MEF2 transcription-enhancing activity increased in
contracting muscle (48). The fact that these mice have been
used to successfully show that MEF2 activity increases with
muscle contraction seems to support our conclusion that the
decrease in GLUT4 expression in denervated muscle is not due
to decreased MEF2 activity, as indicated by the lack of de-
creased reporter gene expression in denervated muscle.
GEF binding to Domain I was measured and found to be
decreased by 50% after denervation. Further evidence for
decreased GEF activity was the finding that total GEF protein
showed a similar trend (P 0.07) with average total GEF 42%
lower in denervated than in control tissue. However, the
hypothesis that decreased GEF activation causes GLUT4 ex-
pression to be depressed seems unlikely given that hGLUT4/
CAT reporter mice with 730 bp of GLUT4 promoter responded
normally to denervation. With the position of Domain I being
from 742 bp to 712 bp in the GLUT4 promoter, it is
truncated in the mice with 730 bp of promoter, and this disrupts
GEF binding. Intact Domain I is required for hormonal regu-
lation, while complete deletion of Domain I abrogates GLUT4
expression. The truncated Domain I contained in the mice with
730 bp of promoter allows for basal GLUT4 regulation, but if
signaling through GEF were responsible for decreased GLUT4
expression, then we would have expected that an intact Do-
main I would have to be present for proper repression of CAT
reporter expression in response to denervation. Therefore,
decreased GEF stimulation through the truncated Domain I
may have played a role in the decline in expression of GLUT4.
To study GLUT4 regulation at the promoter, we focused on
the regions that lie between Domain I and the MEF2 binding
site and between the MEF2 binding site and the basal pro-
moter. The combined effect of the battery of GLUT4/CAT
reporter mice denervated was the deletion or mutation of nearly
all of the GLUT4 promoter except for the MEF2 binding
domain and the basal promoter. CAT reporter gene expression
following denervation was significantly decreased in all trans-
genic lines. These data along with the fact that MEF2 was
rejected as acting as an inhibitor to GLUT4 expression in
denervated muscle due to the normal expression of the lacZ
reporter gene in the MEF2-reporter mice led us to conclude
that the denervation-induced decrease in GLUT4 gene expres-
sion is mediated through the truncated Domain I or the basal
promoter region of the GLUT4 gene.
Previous data from our lab showed, similar to our findings
with CaMK, that GLUT4 content does not decrease in dener-
vated muscle due to a reduction in AMPK activity. However,
mice with increased AMPK activity, due to AICAR treatment,
had greater GLUT4 content after denervation than untreated
controls. This finding is similar to our findings with CaMK in
that mice expressing constitutively active CaMK IV had more
GLUT4 after denervation than did denervated wild-type mice.
Keeping in mind, as Megeney et al. (28) demonstrated, that
denervation is a model of both muscle inactivity and abrogated
neural signaling, we believe that these results demonstrate the
ability of AMPK and CaMK to recover the loss of GLUT4
production due to muscle inactivity, but not the loss of GLUT4
due to decreased neural signaling and delivery of neural trophic
factors. To elucidate this ability, future studies measuring
GLUT4 in an innervated, but inactive, muscle expressing
constitutively active CaMK or treated with AICAR should be
performed.
In summary, the results of this study suggest that decreased
CaMK activity does seem to be responsible for the portion of
GLUT4 lost due to muscle inactivity, but more work will need
to be done to determine the effectiveness of CaMK as a
treatment for inactivity-induced reduction of GLUT4 content.
Regulation by MEF2 does not seem to be involved in the
denervation-induced loss of GLUT4 in muscle, while a role for
GEF seems doubtful but cannot be ruled out yet. The effects,
on GLUT4, of the decreased neural signaling are mainly
mediated by factors other than CaMK, MEF2, and GEF. The
decrease in GLUT4 in denervated muscle appears to be largely
regulated by altered signaling at the basal promoter of the
GLUT4 gene.
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